# Blood Formation, Coagulation, and Thrombosis Agents: Hemophilia Factors\*

## Length of Authorizations

365 Days

## Grandfathering

Patients who have a claim for a non-preferred drug in the previous 120 days will be automatically approved to continue the. Patients who have taken the drug previously but do not have claims history (e.g. new to Medicaid), will need to submit a prior authorization in order to continue coverage.

## Prior Authorization Criteria

1.  Is there any reason the patient cannot use a medication not requiring prior approval? Acceptable reasons include:
    -   Allergy to medications not requiring prior approval
    -   Contraindication to all medications not requiring prior approval
    -   History of unacceptable/toxic side effects to medications not requiring prior approval
2.  Has the patient failed **one** preferred medication?
3.  For extended half-life factors, prescribing physician attests that patient is not a suitable candidate for treatment with shorter-acting half-life product.
4.  If Rebinyn is requested, confirmation that it is not being used for routine prophylaxis
5.  Approval based upon diagnosis and dosage appropriate to weight, patient pharmacokinetic factors, and presence of inhibitors.

## Hemophilia Factor

Blood Formation, Coagulation, and Thrombosis Agents: Hemophilia Factor\*

| PREFERRED       | NON-PREFERRED |
|-----------------|---------------|
| Advate PA       | Jivi          |
| Adynovate PA    | Kovaltry      |
| Afstyla PA      | Nuwiq         |
| Alphanate PA    | Obizur        |
| Alphanine SD PA | Rebinyn       |
| Alprolix PA     | Sevenfact     |
| Benefix PA      | Vonvendi      |
| Corifact PA     |               |
| Eloctate PA     |               |
| Esperoct PA     |               |
| Feiba PA        |               |
| Hemlibra PA     |               |
| Hemofil M PA    |               |
| Humate-P PA     |               |
| Idelvion PA     |               |
| Ixinity PA      |               |
| Koate PA        |               |
| Kogenate FS PA  |               |
| Mononine PA     |               |
| Novoeight PA    |               |
| Novoseven RT PA |               |
| Profilnine PA   |               |
| Recombinate PA  |               |
| Rixubis PA      |               |
| Wilate PA       |               |
| Xyntha PA       |               |

### Link to Criteria

[Blood Formation, Coagulation, and Thrombosis Agents: Hemophilia Factors](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220415_UPDL_Criteria_FINAL_.pdf#page=11)
